Omitting Aspirin in High-Risk Left Ventricular Assist Device Implant

Affiliations

Nosheen Reza. JAMA Cardiol. 2025.

. 2025 Mar 1;10(3):243-244.

doi: 10.1001/jamacardio.2024.4861.

¹ Division of Cardiovascular Medicine, Department of Medicine, Penn Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

No abstract available

Comment in

Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial.
Gustafsson F, Uriel N, Netuka I, Katz JN, Pagani FD, Connors JM, Jorde UP, Zimpfer D, Pya Y, Conway J, Anyanwu A, Scandroglio AM, Sulemanjee N, Atluri P, Keebler M, Selzman CH, Alexis JD, Hayward C, Henderson J, Dirckx N, Gazzola C, Mehra MR; ARIES Investigators. Gustafsson F, et al. JAMA Cardiol. 2025 Mar 1;10(3):235-242. doi: 10.1001/jamacardio.2024.4849. JAMA Cardiol. 2025. PMID: 39774588 Free PMC article. Clinical Trial.

1. Meyer DM, Nayak A, Wood KL, et al. The Society of Thoracic Surgeons Intermacs 2024 Annual Report: focus on outcomes in younger patients. Ann Thorac Surg. Published online October 21, 2024. doi: 10.1016/j.athoracsur.2024.10.003 - DOI - PubMed
1. Mehra MR, Netuka I, Uriel N, et al. ; ARIES-HM3 Investigators. Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: the ARIES-HM3 randomized clinical trial. JAMA. 2023;330(22):2171–2181. doi: 10.1001/jama.2023.23204 - DOI - PMC - PubMed
1. Gustafsson F, Uriel N, Netuka I, et al. ; ARIES Investigators. Aspirin and hemocompatibility after LVAD implantation in patients with atherosclerotic vascular disease: a secondary analysis from the ARIES-HM3 randomized clinical trial. JAMA Cardiol. Published online January 8, 2025. doi: 10.1001/jamacardio.2024.4849 - DOI - PMC - PubMed
1. Hollis IB, Jennings DL, Krim S, et al. An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device. J Heart Lung Transplant. 2024;43(8):1199–1234. doi: 10.1016/j.healun.2024.04.065 - DOI - PubMed
1. Netuka I, Tucanova Z, Ivak P, et al. A prospective randomized trial of direct oral anticoagulant therapy with a fully magnetically levitated LVAD: the DOT-HM3 study. Circulation. 2024;150(6): 509–511. doi: 10.1161/CIRCULATIONAHA.124.069726 - DOI - PubMed